Delivery Order HHSO100201300018I-HHSO10033004T
Award Date
6/11/15
Potential Completion Date
6/9/18
Potential Value
$4.8M
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $6,193,052.00 federal contract was awarded to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract is for the aseptic filling of a magnesium sulfate injection solution into 10mL plastic syringes as part of the Fill and Finish Manufacturing Network (FFMN) program, which aims to establish a network of high-tech pharmaceutical manufacturing...
This is a cost-plus-fixed-fee Delivery Order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a component of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $107,935,344 award supports the clinical development of an FDA-licensed monoclonal antibody countermeasure for exposure to botulinum neurotoxin. The work will involve tasks such as clinical trials, process development, and...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
This is a delivery order award under the Preclinical Services for Biopharmaceutical Product Development Indefinite Delivery Indefinite Quantity (IDIQ) contract, issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $816,039.00 award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) is for stability testing of NTM-1632 and NTM-1633. This award does not...
This is a $190,241,861.21 Other Transaction Agreement awarded by the Department of the Army's Joint PEO Chemical and Biological Defense to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company. The contract does not have a set-aside designation. The agreement, awarded on February 21, 2020, supports the development and manufacturing of medical countermeasures against biological threats and COVID-19. Resilience has provided...
This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chrysalis Biotherapeutics, Inc. The contract is for "A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION" and has a ceiling value of $6,954,508.60. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of August 31, 2021. The...
This is a federal contract award to Regeneron Pharmaceuticals Inc., a for-profit manufacturer of pharmaceuticals and therapeutics. The $692,086,314.00 award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is for the development and production of "novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens" under an Other...
This is a $19,000,000.00 Other Transaction Agreement (OTA) awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) to On Demand Pharmaceuticals Inc., a for-profit pharmaceutical company. The contract is for the production of cisatracurium drug substance (active pharmaceutical ingredient, or API) and drug product, as part of a prototyping effort for a distributed manufacturing network for critical medicines. The contract...
This federal contract award, valued at $2,455.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Succinylcholine 200 mg/10 ml, a critical pharmaceutical product, to support military healthcare programs. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...